This is the authors' abstract. We don't add key points for this paper.
Colorectal cancer rates are rapidly increasing worldwide, and traditional endoscopy services cannot keep up with the demand. The COVID-19 pandemic has accelerated the adoption of colon capsule endoscopy (CCE) as a groundbreaking, minimally invasive option that will redefine lower gastrointestinal investigation through the implementation of artificial intelligence (AI). This paper argues that AI has the potential to transform CCE by replacing labor-intensive manual reviews with streamlined polyp matching and characterization through efficient AI-assisted detection. Our proposal is that of an AI-driven CCE model where it is feasible to scale up, for example, through home capsule delivery, cloud-based systems, and same-day colonoscopy solutions. Clinicians must reassess how an AI-driven intervention will fit within the current classical diagnostic pathway. Embracing this transformative advancement is essential; we can no longer rely on traditional diagnostic endoscopy given the ever-increasing volume, cost pressures and environmental impact.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: